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The role of green tea polyphenon-60 (PP-60) in decreasing metabolic risk factors, oxidative
stress, and inflammation and in the amelioration of cardiac apoptosis in experimentally
induced diabetes was investigated. After the induction of diabetes in male rats by strep-
tozotocin (STZ; 50 mg/kg, i.p.), PP-60 (100 mg/kg) was orally administered for two weeks.
The treatment of the diabetic rats with PP-60 ameliorated hyperglycemia and HbA1c,
increased insulin secretion, improved the HOMA-IR level and lipid profile and increased the
levels of IL-1b, IL-6, and TNF-a. PP-60 also blunted the increase in the level of MDA and
H2O2 and the decreases in the levels of GSH, SOD, and CAT in the heart of STZ-treated rats
and improved heart function. PP-60 decreased the apoptosis of cardiomyocytes; enhanced
Bcl-2 expression; blocked the increases in p53, Bax, caspases 9, 8 and 3; and ameliorated
DNA damage in the heart. Our data suggests that PP-60 decreased apoptosis by blocking
DNA damage via the action of caspases and the suppression of pro-inflammatory cyto-
kines. The pleiotropic effects of PP-60, including its anti-hyperglycemic effect, hypolipi-
demic influence, attenuation of oxidative stress reduction of circulating pro-inflammation
cytokines and anti-apoptotic action through modulation of its related regulated proteins,
contribute to and accompany the beneficial effects of treatment with PP-60 on diabetic
heart dysfunction.
Copyright 2015, Mansoura University. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Diabetes mellitus is one of the most common endocrine
metabolic disorders and is associated with marked morbidity(M.A. El-Missiry).
ra University.
sity. Production and hosti
licenses/by-nc-nd/4.0/).and mortality due to cardiac complications [1,2]. The patho-
physiology underlying diabetes-induced cardiac damage is
complex and is induced by several factors, including elevated
oxidative stress, high proinflammatory cytokines and dysli-
pidemia as the main risk factors [3]. It was recently reportedng by Elsevier B.V. This is an open access article under the CC BY-
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tion, increases the oxidative stress levels, and results in car-
diac apoptosis as early as three weeks after diabetic induction
in rats [4]. A similar finding was reported after the adminis-
tration of streptozotocin (STZ) for four days [5].
In diabetes, the dysregulation of programmed cell death is
a significant factor of cardiomyopathy. In human and animal
models of diabetes, cardiac pathology is associated with
excessive apoptosis [5,6] that progressively leads to histo-
pathological features and eventually to heart disease [7,8].
Overwhelming evidence indicates that cardiomyocyte
apoptosis in diabetes is associated with cytopathological fea-
tures [9,10], which is likely a direct result of hyperglycemia-
triggered caspase 3 activation [3,11]. There are two pathways
known to produce cardiac apoptosis, namely the mitochon-
drial and the death receptor-mediated pathways, and both are
influenced by cellular antioxidants [5]. Caspases 8 and 9 are
initiator caspases for the extrinsic and intrinsic pathways,
respectively, and caspase 3 is activated by both pathways and
initiates apoptosis. The early event of myocyte apoptosis is
characterized by nuclear damage, which is often undetectable
morphologically, but DNA damage can be identified by several
techniques, including the comet assay. The initial phase of the
apoptotic process is followed by nuclear fragmentation and
later by cytoplasmic alterations [12,13]. In diabetes, oxidative
stress is the key element in all of mechanisms underlying
cardiomyopathy and apoptosis, both of which are associated
with hyperglycemia and hyperlipidemia [3].
Beyond the beverage use of tea, naturally derived catechins
have been recognized to have numerous health benefits.
However, the molecular mechanisms through which these
molecules mediate their effects remain largely unknown
[14,15]. Green tea is obtained from the fresh leaves of the
Camellia sinensis plant and is processed to prevent oxidation of
the polyphenolic constituents [16]. Experimental and clinical
studies have confirmed the efficacy of phytochemicals in the
modulation of oxidative stress-induced cardiovascular dis-
eases associated with diabetes [17,18]. Catechins are flavanols
that constitute the majority of soluble solids of green tea.
EGCG [()-epigallocatechin-3-gallate] is the main catechin [19]
and ECG [()-epicatechin-3-gallate] is the second most
concentrated catechin component of green tea. Other major
catechins found in green tea include ()-epicatechin (EC) and
()-epigallocatechin (EGC) [20]. Catechins afford an antioxi-
dant effect by inducing antioxidant enzymes, inhibiting pro-
oxidant enzymes and scavenging free radicals [16]. The po-
tential mechanisms underlying the antioxidant effects of tea
as effective scavengers of physiologically relevant reactive
oxygen and nitrogen species were reviewed previously. The
aromatic phenol rings present in these molecules cause them
to behave as antioxidants by reducing free radicals and
chelating metals in the body [21].
Catechins of green tea, particularly EGCG, have antioxidant
activity [22], antidiabetic activity and antiobesity [23] as well
as anti-inflammatory activities [24,25], and can modulate
apoptotic processes in the liver [26]. EGCG binds to low-
density lipoproteins (LDL) and protects them from glycation
and oxidation under high-glucose medium, which mimics
diabetes. Oxidized LDL and soluble vascular cell adhesion
molecule-1 are markedly decreased after 30 days of green teaingestion [27]. Oral treatment with green tea polyphenol offers
cardioprotection against ischemia-reperfusion injury in an
isolated rat heart model [28]. Plyphenol-60 (PP-60) has a ther-
apeutic effect on acne by suppressing inflammation, specif-
ically by inhibiting IL-8 secretion [29].
The beneficial effects of green tea are related to catechins,
particularly EGCG [30]. However, no previous study has
investigated the efficacy of polyphenon-60, which contains
pure catechins, mainly EGCG, in diabetes-induced cardiomy-
opathy in rats. In addition, the mechanisms involved in its
beneficial effects are not fully understood. Therefore, the
present study was designed to evaluate the cardio-
ameliorative effects of polyphenon-60 in STZ-induced early
cardiac injury in rats and attempts to understand the mech-
anism underlying the therapeutic effects of this compound
with reference to biochemical and molecular markers.2. Materials and methods
2.1. Chemicals
Green tea polyphenol (polyphenon-60) and streptozotocin
(STZ) were purchased from Sigma (Sigma, St. Louis, MO, USA).
2.2. Experimental design and animal groups
Male Wistar rats weighing approximately 250e300 g were
obtained from the Laboratory Animal Maintenance Unit,
Faculty of Science, Mansoura University and acclimatized to
the laboratory conditions for two weeks. They were main-
tained at 25 ± 2 C and a 12-h light/12-h dark cycle. The rats
were given standard commercial rat chow and water ad libi-
tum. All of the experiments were conducted in accordance
with protocols approved by the local ethical committee for
in vivo animal experiments. The animals were divided into
four groups of eight rats each. The first group served as a
control. The second group received an oral dosage of
polyphenon-60 (100 mg/kg body wt) every other day for a
period of two weeks. The third group received a single i.p.
injection of STZ (40 mg/kg body wt). The diabetic state of the
rats was confirmed by determination of the blood glucose
level after two days of STZ injection. The fourth group
received STZ followed by green tea polyphenon-60 at the same
doses as the second and third groups.
After two weeks of treatments, overnight fasted rats were
anaesthetized with sodium pentobarbital (50 mg/kg i.p.), and
their blood was collected by cardiac puncture. The sera were
separated by centrifugation (500 g) for 5 min for biochemical
determinations. The heart samples were homogenized in 10
volumes of 50mM sodiumphosphate buffer (pH 7.4) at 4 C for
30 s. The homogenate was centrifuged (1000 g) for 5 min in a
refrigerated centrifuge. The resulting supernatant was used
for the biochemical determinations.
2.3. Biochemical analysis
The blood glucose, insulin and HbA1c levels were estimated
using kits supplied by Spinreact (St. Esteve d'en Bas Girona,
Spain), Abcam (Cambridge, MA, USA) and BioSystems
Fig. 1 e Effect of polyphenon-60 on blood glucose and body
weight in the different animal groups during the
experimental period. The values are expressed as the
means ± S.D. (n ¼ 6). a&d Significant at P < 0.05, b&e
Significant at P < 0.01, c&f Significant at P < 0.001. a, b & c
indicate comparisons with respect to the control group. d, e
& f indicate comparisons with respect to the diabetic
group.
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lipids, including total lipids, triglyceride, total cholesterol,
high-density lipoprotein (HDL), low-density lipoprotein (LDL),
very low-density lipoproteins (VLDL), was assayed following
the kit's instructions (Spinreact, St. Esteve d'en Bas Girona,
Spain). The heart function was estimated by determining the
creatine kinase (CK-MB) and lactic dehydrogenase (LDH) ac-
tivities using kits purchased from Elitech (Puteaux, France).
The lipid peroxidation was estimated by measuring the
amount of malondialdehyde (MDA). The hydrogen peroxide
(H2O2) concentrations were determined following the kit's
instructions (Dokki-Giza, Egypt). The antioxidant levels were
estimated by determining superoxide dismutase (SOD) activ-
ity, catalase (CAT) activity, and glutathione (GSH) content
using kits supplied by Biodiagnostic (Dokki-Giza, Egypt). The
pro-inflammatory markers interleukin 6 (IL-6), interleukin 1
beta (IL-1b) and tumor necrosis factor alpha (TNF-a) were
estimated according to kits purchased from R&D Systems (NE
Minneapolis, MN, USA) and EBioscience (San Diego, CA, USA).
The protein concentrations were determined as previously
described [31].
2.4. Molecular analysis
Heart samples were prepared for flow cytometry as previously
described [32]. The cells obtained were suspended in PBS with
BSA, divided into aliquots collected in round-bottom tubes
(Becton Dickinson) and stored at 4 C for flow cytometric an-
alyses. The flow cytometric analyses were performed on a
FACSCalibur™ cytometer (BD Biosciences, San Jose, CA, USA)
using the CellQuest Pro software (Becton Dickinson) for data
acquisition and analysis [33].
2.5. Flow cytometric analysis of apoptosis with Annexin
VeFITC/PI staining
Apoptosis in the heart samples was probed using fluorescein
isothiocyanate-conjugated annexin V/PI with the ApoAlert kit
from Clontech (Palo Alto, CA, USA) according to the manu-
facturer's instructions. The flow cytometric analyses were
performed on a FACSCalibur™ cytometer (BD Biosciences, San
Jose, CA, USA) using the CellQuest Pro software (Becton
Dickinson) for data acquisition and analysis [33].
2.6. Flow cytometric analysis of Bcl-2 and Bax
Heart samples were prepared with PBS/BSA buffer and then
incubated with anti-Bcl-2 [100/D5] antibody (ab692) or anti-
Bax [6A7] antibody (ab5714) for 15 min at room temperature.
The cells were then resuspended in 0.5% paraformaldehyde in
PBS/BSA and analyzed by flow cytometry.
2.7. Flow cytometric analysis of P53
The cell suspensions were prepared with a PBS/BSA buffer,
incubated with antibody (mouse anti-P53 “aa20-25” FITC,
Clone: DO-1), mixed well and incubated for 30 min at room
temperature. The cells were washed with PBA/BSA and
centrifuged at 400 g for 5 min, and the supernatant was
discarded. The cells were then resuspended in 0.5%paraformaldehyde in PBS/BSA and analyzed using a flow cy-
tometer [34].
2.8. Flow cytometric analysis of CD95
The cell suspensions were prepared with a PBS/BSA buffer,
incubated with antibody (monoclonal anti-Fas (CD95/Apo-1)
antibody), mixed well and incubated for 30 min at room
temperature. The cells were washed with BD Perm/Wash (BD
Bioscience) and centrifuged at 400 g for 5 min, and the su-
pernatant was discarded. The cells were then resuspended in
BD Perm/Wash and analyzed by flow cytometry.
2.9. Flow cytometric analysis of caspases 3, 8 and 9
The cell suspensions were prepared with a PBS/BSA buffer,
incubated with antibody FITC rabbit anti-active caspase-3
antibody (CPP32; Yama; Apopain, BD Bioscience); anti-
caspase-8 (E6) antibody (Abcam); or rabbit monoclonal anti-
caspase 9 (E23) antibody (ab32539), mixed well and incu-
bated for 30 min at room temperature. The cells were washed
with BD Perm/Wash (BD Bioscience) and centrifuged at 400 g
Fig. 2 e Effect of polyphenon-60 on the serum levels of glucose (mg/dl), insulin (pg/ml), blood HbA1c percentage and HOMA-
IR percentage of the experimental groups at the end of the experimental period. The values are expressed as the
means ± S.D. (n ¼ 6). a&d Significant at P < 0.05, b&e Significant at P < 0.01, c&f Significant at P < 0.001. a, b & c indicate
comparisons with respect to the control group. d, e & f indicate comparisons with respect to the diabetic group.
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then resuspended in BD Perm/Wash and analyzed by flow
cytometry.
2.10. Single-cell gel electrophoresis (comet assay)
The DNA damage in the heart samples was assessed using the
single-cell gel electrophoresis (comet assay) method, a well-
validated technique developed for measuring DNA strand
breaks in individual cells, as described previously [35,36]. The
quantification of the DNA from the obtained images was
performed with the CASP software, which allows the direct
determination of the percentage of DNA in the tail.
2.11. Statistical analysis
The data are presented as the means ± S.D. The statistical
analyses were performed by one-way ANOVA followed byTable 1 e Effect of polyphenon-60 on the serum lipid profile (to
density lipoprotein (HDL), low-density lipoprotein (LDL), and v
the different animal groups.
Control PP-60
Total Lipid 438 ± 5.3 371 ± 20.5
Cholesterol 81.54 ± 6.2 80.19 ± 2.61
Triglyceride 58.12 ± 6.8 46.21 ± 5.6
LDL 28.49 ± 5.017 29.06 ± 1.60
HDL 41.44 ± 2.5 41.92 ± 2.2
VLDL 11.61 ± 1.3 9.21 ± 1.1
The values are expressed as the means ± S.D. (n ¼ 6). a&d Significant at P
indicate comparisons with respect to the control group. d, e & f indicateStudents NewmaneKeuls post-hoc test. Statistical signifi-
cance was considered as P < 0.05.3. Results
The effect of polyphenon-60 on blood glucose and bodyweight
in the different animal groups was studied during the exper-
imental period. The body weight of the diabetic rats was
gradually decreased during the experimental period
compared with that of the control group. The treatment of the
diabetic rats with PP-60 (100 mg/kg) resulted in a marked
amelioration along the experimental period compared with
the diabetic group (Fig. 1a). The blood glucose of the diabetic
rats was significantly increased during the experimental
period compared with that of the control group. The treat-
ment of the diabetic rats with PP-60 resulted in a marked
amelioration along the experimental period compared withtal lipids (TL), cholesterol (Ch), triglycerides (TG), high-
ery-low-density lipoprotein (VLDL)) expressed as mg/dl in
STZ STZ þ PP-60
a 1055 ± 26.4 c 575 ± 12.8 c, f
8 145.6 ± 6.1 c 95.96 ± 3.1 f
146.8 ± 18.8 b 75.18 ± 7.7 e
9 94.70 ± 8.8 c 39.02 ± 5.1 f
23.72 ± 1.50 c 40.90 ± 1.5 f
27.70 ± 3.35 b 15.04 ± 1.5 e
< 0.05, b&e Significant at P < 0.01, c&f Significant at P < 0.001. a, b & c
comparisons with respect to the diabetic group.
Fig. 3 e Effect of polyphenon-60 on the activities of serum
CK-MB and LDH expressed as U/ml in the different animal
groups. The values are expressed as the means ± S.D.
(n¼ 6). a&d Significant at P < 0.05, b&e Significant at P < 0.01,
c&f Significant at P < 0.001. a, b & c indicate comparisons
with respect to the control group. d, e & f indicate
comparisons with respect to the diabetic group.
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lower than that of the control group.
STZ treatment produced a significant elevation in the
serum glucose and HbA1c levels two weeks after injection
(Fig. 2a and b). These diabetic rats had significantly higher
HOMA-IR levels and secreted significantly less insulin than
the control group (Fig. 2c and d). The oral treatment of the
diabetic rats with PP-60 showed a significant effect on the
serum glucose and HbA1c levels and presented significantly
higher insulin and HOMA-IR values compared with that of the
diabetic rats.
Compared with the control group, the lipid profile,
including the levels of total lipids, triglycerides, total choles-
terol, low-density lipoprotein and very-low lipoprotein, was
significantly higher, whereas the level of high-density lipo-
protein was significantly lower in the diabetic rats (Table 1).
The treatment of the diabetic rats with PP-60 caused marked
amelioration of the lipid fractions toward the control levels
compared with the diabetic group (Table 1).
The diabetic rats showed significantly higher activities of
CK-MB and LDH in the serum compared with the control
values. The oral treatment with PP-60 after diabetic induction
normalized the increase in the activities of these enzymes and
demonstrated insignificant changes compared with those of
the control group (Fig. 3).
A significant increase in lipid peroxidation was demon-
strated in the heart of the diabetic rats, as indicated by the
increase in the MDA and H2O2 concentrations after STZ
treatment (Table 2). A marked control of lipid peroxidation
and generation of H2O2 in the heart against the diabetic-
induced increase in the MDA level and generation of H2O2
by the oral administration of PP-60 after STZ treatment was
demonstrated. The cardiac content of GSH and activities of
SOD and CAT significantly decreased after diabetic induc-
tion by STZ. This effect was significantly prevented in the
heart by the oral administration of PP-60 into the diabetic
rats.
The degree of apoptosis in the heart was assessed through
flow cytometric analysis with Annexin V-FITC staining (Fig. 4).
The data demonstrate that the percentage of apoptotic cells
was significantly higher in the heart of the diabetic rats
compared with the controls (Fig. 4a). Treatment with PP-60
significantly minimized the number of apoptotic cells
compared with the diabetic rats. In addition, DC95 was
significantly increased in the heart of diabetic rats compared
with the controls (Fig. 4b). The effects of PP-60 and diabetes on
specific apoptotic proteinswere assessed. The flow cytometric
analysis demonstrated that the anti-apoptotic protein Bcl-2
was significantly decreased and that the apoptotic protein
Bax was increased in the heart of diabetic rats and that
treatment with PP-60markedly normalized the changes in the
expression of these proteins (Fig. 4c and d). The expression of
caspases 9, 8 and 3 was strongly detected in the heart of the
diabetic rats, and the treatment with PP-60 significantly
inhibited the diabetes-induced activation of these apoptotic
proteins (Fig. 5aec).
The diabetic rats had significantly higher levels of IL-1b, IL-
6, and TNF-a compared with the control values. The oral
treatment with PP-60 after diabetic induction normalized the
increase in the levels of these cytokines in the serum anddisplayed insignificant changes compared with those of the
control (Fig. 6aec).
The rats in both the control and PP-60-treated groups had
lower levels of both the percentage of p53 and tail DNA in the
hearts compared with the diabetic rats, with the latter
appearing to be more severe than the former (Fig. 7a), sug-
gesting oxidative DNA damage in the diabetic rats. The
treatment of diabetic rats with PP-60 significantly ameliorated
both the percentage of tail DNA and p53 in the heart compared
with the diabetic rats (Fig. 7b).4. Discussion
There is increasing evidence of a protective effect of green tea
catechins against cardiac disease. The present results
demonstrate the mechanism underlying the antiapoptotic
action of green tea PP-60 synchronized with amelioration of
metabolic risk factors and oxidative stress as well as the
modulation of proinflammatory cytokines in STZ-diabetic
rats.
The results demonstrated a significant improvement in the
levels of serum glucose and HbA1c accompanied with a
marked amelioration of insulin release and HOMA-IR in the
diabetic rats treated with PP-60. Previous studies have shown
Table 2 e Effect of polyphenon-60 on the levels of the lipid peroxidation product MDA (nmol/mg protein), hydrogen
peroxide (H2O2), glutathione (GSH; mg/g protein) superoxide dismutase (SOD; U/mg protein) and catalase (CAT; U/mg
protein) in the heart in the different animal groups.
Control PP-60 STZ STZ þ PP-60
MDA 6.43 ± 0.65 6.9 ± 0.57 14.87 ± 0.79 c 5.8 ± 0.18 f
H2O2 0.48 ± 0.03 0.45 ± 0.01 1.15 ± 0.08 c 0.54 ± 0.02 f
SOD 58.88 ± 3.484 67.63 ± 2.489 40.44 ± 2.434 b 59.92 f ± 1.790
CAT 1.045 ± 0.04602 1.917 ± 0.1726 b 0.4657 ± 0.08651 c 1.139 ± 0.1385 e
GSH 88.6 ± 1.83 95.26 ± 3.99 29.83 ± 4.70 c 119.4 ± 30.36 d
The values are expressed as the means ± S.D. (n ¼ 6). a&d Significant at P < 0.05, b&e Significant at P < 0.01, c&f Significant at P < 0.001. a, b & c
indicate comparisons with respect to the control group. d, e & f indicate comparisons with respect to the diabetic group.
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the sodium-dependent glucose transporter SGLT1 [37], acti-
vates glucose uptake, and mimics insulin in that it decreases
the expression of genes that control gluconeogenesis [38].
Moreover, EGCG increases the tyrosine phosphorylation of the
insulin receptor and insulin receptor substrate [39]. Further-
more, the administration of 100 mg/kg PP-60 markedly
improved the body weight loss in the diabetic rats in com-
parison with the diabetic group. This is likely due to theFig. 4 e Effect of polyphenon-60 on the percentage of apoptosis
cytometry data showing examples of data generated by FACS o
means ± S.D. (n ¼ 6). a&d Significant at P < 0.05, b&e Significant
comparisons with respect to the control group. d, e & f indicateprotective effect of green tea catechins in decreasing gluco-
neogenesis and regulating muscle loss [40].
The present study showed that green tea PP-60 may in-
crease the heart antiglycating activity produced by diabetes,
as previously observed in aortic tissue [41], and this finding
was supported by a decrease in HB-A1c in the PP-60-treated
diabetic rats (Fig. 2). This finding is supported by the present
findings that PP-60 ameliorates the elevation of IL-1b, IL-6, and
TNF-a in the sera of diabetic rates treated with PP-60. It has, DC-95, Bcl-2 and Bax in the different animal groups. Flow
n top of each histogram. The values are expressed as the
at P < 0.01, c&f Significant at P < 0.001. a, b & c indicate
comparisons with respect to the diabetic group.
Fig. 5 e Effect of polyphenon-60 on the percentage of caspases 3, 8 and 9 in the different animal groups. Flow cytometry data
showing examples of data generated by FACS at the side of each histogram. The values are expressed as the means ± S.D.
(n ¼ 6). a&d Significant at P < 0.05, b&e Significant at P < 0.01, c&f Significant at P < 0.001. a, b & c indicate comparisons with
respect to the control group. d, e & f indicate comparisons with respect to the diabetic group.
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sition 3 plays an essential role in the protection against pro-
tein oxidation and glycation [42].
In line with these findings, PP-60 significantly reduced
HOMA-IR in STZ-diabetic rats (Fig. 2), supporting the finding
that green tea catechin improves the insulin resistance of
diabetic rats. Similarly, the HOMA-IR index has been found to
increase when dogs become obese and decreases after green
tea treatment [43]. It is possible that green tea increases
GLUT4 translocation in muscle cells [43]. EGCG also inhibits
dexamethasone-induced insulin resistance through the
AMPK and PI3K/Akt pathways [44]. This finding implies that
PP-60 may protect against insulin sensitivity and improves
glucose homeostasis. Previous studies have also shown that
EGCG may increase insulin activity [45,46]. Thus, supple-
mentation with PP-60 ameliorates risk factors, improves
glucose homeostasis and may be beneficial to diabetes for
preventing possible early cardiac events.
Hyperglycemia is not the only major factor affecting
cardiac complications. Dyslipidemia has been reported to be
particularly important for the development of cardiomyop-
athy [6,47]. Therefore, improvement of the lipid profile in
serum is a feasible health strategy that considers thetherapeutic potential of EGCG on cardiovascular disease.
Both experimental and clinical studies have suggested that
EGCG may have such an effect [46,48]. The administration of
PP-60 to the diabetic rats significantly lowered the serum
levels of total cholesterol, triglycerides, and low-density and
very-low-density lipoproteins and resulted in a significantly
higher serum level of high-density lipoprotein compared
with the diabetic rats. Previous studies have shown that
catechin extracted from green tea improves the serum lipid
profile in rats fed an atherogenic diet [49] and injected with
STZ [50] and in obese patients with metabolic syndrome
[51]. A recent study showed that the tea polyphenol EGCG
actually binds to lipoprotein particles and facilitates the LDL
antioxidant and anti-glycation activities in a high glucose
environment. Lowering the levels of serum lipid risk factors
through dietary polyphenol treatment appears to be the
main scheme for decreasing the threat of cardiac disease
and related complications [52,53]. These results indicate
that EGCG is the major component of polyphrnol-60 that
has a beneficial effect for protecting against risk of cardiac
disease by improving the lipid levels. Thus, EGCG is a pri-
mary agent in LDL-lowering therapy for the reduction of
cardiac risk.
Fig. 6 e Effect of polyphenon-60 on the serum IL-1b, IL-6,
and TNF-a levels expressed as pg/ml in the different
animal groups. The values are expressed as the
means ± S.D. (n ¼ 6), a&d Significant at P < 0.05, b&e
Significant at P < 0.01, c&f Significant at P < 0.001. a, b & c
indicate comparisons with respect to the control group. d, e
& f indicate comparisons with respect to the diabetic
group.
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increased events of oxidative stress were found in the heart of
the diabetic rats. Treatment with PP-60 evidently prevented
the diabetes-induced decrease in SOD and CAT activities and
MDA formation, which culminated into a marked ameliora-
tion of oxidative stress in the heart tissue. Oxidative stress
leads to the accumulation of the lipid peroxidation product
MDA in the heart and causes impaired cell function. Mounting
evidence strongly indicates the potency of the free-radical-
scavenging abilities of catechins due to the presence of the
C-ring gallate group. Galloylated catechins, including PP-60,
are strong antioxidants due to their higher phospholipid/
water partition coefficients and hence have the protective
properties of the membrane phospholipids [54]. Green tea
extract can decrease lipid peroxidation markers, includinglipid hydroperoxides, 4-hydroxynonenal and malondialde-
hyde, in the liver, serum and brain [55]. These results confirm
the ability of PP-60 to attenuate oxidative stress in the heart.
Marked increased in the serum CK-MB and LDH activities
were demonstrated in the diabetic group, suggesting the
incidence of significant injury in the membrane of car-
diomyocytes, likely due to lipid peroxidation, and the leaking
of the functional marker enzymes into the blood. After PP-60
treatment, the diabetic rats presented significant reductions
in the elevated activities of CK-MB and LDH, demonstrating
the efficiency of green tea catechin for the protection of car-
diomyocyte integrity. This finding agrees with the ability of
EGCG to significantly decrease reactive oxygen species (ROS)
and cytosolic Ca2þ and to prevent alterations in the protein
expression of the adherens molecules b-catenin and N-cad-
herin and the gap junction protein connexin 43 in cardiac cells
[56]. Green tea significantly reduces the serum biomarker
levels, increases the antioxidants levels in cardiac tissue and
restores electrocardiographic changes compared with the
isoproterenol-only-treated group [57] as well as reduces
cyclophosphamide-induced myocardial toxicity [58]. These
data clearly show that PP-60 is effective against cardiac stress.
The upregulation of the pro-inflammatory cytokine TNF-a,
which increases after increases in ROS and oxidative stress,
has emerged as a significant contributor to myocardial heart
failure [59,60]. The effect of hyperglycemia-induced oxidative
stress on inflammation has been documented by numerous
studies [61,62]. A previous study found that the levels of IL-6,
TNF-a and IL-18 were increased significantly in patients with
impaired glucose tolerance [63,64]. Therefore, it has been hy-
pothesized that polyphenols can modulate cellular signaling
processes during inflammation due to their antioxidant
properties. It has been reported that green tea extract reduces
the serum levels of TNF-alpha, insulin, and free fatty acid and
decreases the mRNA expression level of TNF-alpha, inter-
leukin (IL)-6, IL-1b, and IL-18 in the liver of obesemice [65] and
prevents cardiac fibrosis by attenuating TNF-a [66]. TNF-a is
critical for the induction of the inflammatory response.
Experimentally induced diabetes mellitus is characterized by
intramyocardial inflammation, including increased TNF-a
expression and myocardial fibrosis [67]. Hyperglycemia can
produce ROS, which in turn triggers TNF-a gene expression,
and treatment with the ROS scavenger N-acetylcysteine
significantly reduces the hyperglycemia-induced TNF-a [68].
Our experimental results are consistentwith those of previous
studies, which have revealed that the circulating IL-1b, IL-6,
and TNF-a levels are elevated in STZ-induced diabetic rats
[67], and agree with the results of a study that showed that
EGCG reduces the expression of IL-6 and TNFa in the heat of an
I/R injury model by decreasing NFkB [69]. We further observed
that PP-60 suppresses the elevated level of these cytokines. In
conjunction with the hypoglycemic and antioxidant activities
of tea catechins, the results imply that PP-60 may reduce pro-
inflammatory cytokines by modulating the glucose levels and
oxidative stress in the heart of diabetic rats.
To investigate the mechanism underlying the action of PP-
60 on cardiac apoptosis in diabetes, we determined the levels
of apoptosis and related regulatory proteins in the heart of
STZ-induced diabetic rats before and after PP-60 treatment. In
the diabetic group, the numbers of both apoptotic and necrotic
Fig. 7 e Effect of polyphenon-60 on the percentage of P53 assessed by flow cytometer (a) and % DNA in the tail assessed by
comet assay (b). Flow cytometry data showing examples of data generated by FACS on top of the histogram. The values are
expressed as the means ± S.D. (n¼ 6), a&d Significant at P < 0.05, b&e Significant at P < 0.01, c&f Significant at P < 0.001. a, b &
c indicate comparisons with respect to the control group. d, e & f indicate comparisons with respect to the diabetic group.
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group, whereas PP-60 markedly reduced the numbers of these
cells. In addition, PP-60 normalized the levels of CD95, cas-
pases 8, 9, and 3 and Bax in the same group. These results
indicate a marked modulation of both extrinsic and intrinsic
apoptotic pathways in the heart of PP-60-treated diabetic rats
and provide evidence that EGCG has the ability to modulate
apoptotic pathways in diabetes. EGCG protects against sub-
sequent apoptosis following I/R injury in cardiac surgery by
regulating the Bcl-2/Bax ratio and blocking the cleavage of
caspase 3 [28]. Similarly, EGCG increases the expression levels
of Bcl-2, Mn-superoxide dismutase, and catalase, decreases
the levels of Bax and increases the ratio of Bcl-2/Bax in iso-
lated rat hearts [70]. In addition, EGCGmodulates apoptosis by
preventing the expression of the proapoptotic genes Bax, Bad
and Mdm2 while inducing the anti-apoptotic genes Bcl-2, Bcl-
w and Bcl-xL in SH-SY5Y cells [71]. These results show that
EGCG, which is themost abundant antioxidant catechin in PP-
60, exerts a protective effect on cardiac injury by acting as an
antioxidant and anti-apoptotic agent.
The present results further show that the mechanismmay
be related to the inhibitory effects of PP-60 on p53 induction
and DNA damage. A previous study demonstrated that p53
plays an important role in cardiomyocyte apoptosis in cardiac
hypertrophy because the upregulation of the p53 and its
dependent genes is important in the modulation of myocyte
apoptosis in heart failure [71]. The present results demon-
strated obvious DNA damage with a markedly high fraction of
tail DNA and typical comet-like nuclei, which are indicative of
increased DNA damage in the hearts of diabetic rats. Thus,
apoptosis results in nuclear fragmentation via the action of
caspases as well as pro-inflammatory cytokine release.
The oral treatment of diabetic rats with PP-60 inhibits the
increase in the comet parameter compared with diabetic rats.The mechanism of protection may be attributed to the effec-
tive antioxidant and scavenging free radical potential of
catechin. These data confirm recent reports that EGCG
markedly protects against DNA damage and oxidative stress
in different cells and tissues, including human leucocytes [72],
human mucosa cell cultures [73] and liver cells [74]. PP-60
treatment effectively upregulates Bcl-2, downregulates p53
and protects against DNA damage. Hyperglycemia activates
p53 and p53-regulated genes leading to myocyte cell death
[13]. It has been reported that p53 can act to regulate the
intracellular redox state and induces apoptosis by a pathway
dependent on ROS production [71,75]. In contrast, Bcl-2 exerts
anti-apoptotic and anti-necrotic effects through its antioxi-
dant influence on intracellular ROS [6,76]. Bcl-2 may decrease
lipid peroxidation by enhancing cell resistance to ROS and
preventing ROS production [71]. Therefore, we propose that
the anti-apoptotic effect of PP-60 by decreasing p53 induction
and the decrease in Bcl-2 may be related, at least in part, to its
antioxidant impact. It appears that PP-60 decreases apoptosis
by blocking DNA damage via the action of caspases and pro-
inflammatory cytokine suppression.5. Conclusions
The modulation of pro-inflammatory and pro-apoptotic
pathways by green tea catechins in the diabetic heart may
be an additional pathophysiological mechanism that prevents
further consequences of the diabetic heart and beneficially
prevents progression of the complication. It appears that the
pleiotropic effects of polyphenon-60, including its anti-
hyperglycemic effect, its influence of hypolipidemia, its
attenuation of the oxidative stress reduction induced by
circulating pro-inflammation cytokines and its anti-apoptotic
e g y p t i a n j o u rn a l o f b a s i c a n d a p p l i e d s c i e n c e s 2 ( 2 0 1 5 ) 1 2 0e1 3 1 129action through the modulation of its related regulated pro-
teins, contribute to and accompany the beneficial effects of
treatment with PP-60 on diabetic heart dysfunction.
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